UniProt ID | RL29_HUMAN | |
---|---|---|
UniProt AC | P47914 | |
Protein Name | 60S ribosomal protein L29 | |
Gene Name | RPL29 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 159 | |
Subcellular Localization | ||
Protein Description | Component of the large ribosomal subunit.. | |
Protein Sequence | MAKSKNHTTHNQSRKWHRNGIKKPRSQRYESLKGVDPKFLRNMRFAKKHNKKGLKKMQANNAKAMSARAEAIKALVKPKEVKPKIPKGVSRKLDRLAYIAHPKLGKRARARIAKGLRLCRPKAKAKAKAKDQTKAQAAAPASVPAQAPKRTQAPTKASE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Ubiquitination | -----MAKSKNHTTH -----CCCCCCCCCC | 61.74 | 24816145 | |
4 | O-linked_Glycosylation | ----MAKSKNHTTHN ----CCCCCCCCCCH | 29.20 | 28510447 | |
5 | Methylation | ---MAKSKNHTTHNQ ---CCCCCCCCCCHH | 52.63 | 12962325 | |
8 | Phosphorylation | MAKSKNHTTHNQSRK CCCCCCCCCCHHHHH | 38.86 | 28152594 | |
9 | Phosphorylation | AKSKNHTTHNQSRKW CCCCCCCCCHHHHHH | 15.98 | 28152594 | |
13 | O-linked_Glycosylation | NHTTHNQSRKWHRNG CCCCCHHHHHHHHCC | 40.94 | 28510447 | |
23 | Ubiquitination | WHRNGIKKPRSQRYE HHHCCCCCCHHHHHH | 43.68 | 24816145 | |
26 | Phosphorylation | NGIKKPRSQRYESLK CCCCCCHHHHHHHHC | 27.77 | 28152594 | |
29 | Phosphorylation | KKPRSQRYESLKGVD CCCHHHHHHHHCCCC | 11.39 | 28152594 | |
31 | Phosphorylation | PRSQRYESLKGVDPK CHHHHHHHHCCCCHH | 26.84 | 23401153 | |
33 | Acetylation | SQRYESLKGVDPKFL HHHHHHHCCCCHHHH | 67.19 | 19608861 | |
33 | Ubiquitination | SQRYESLKGVDPKFL HHHHHHHCCCCHHHH | 67.19 | 23000965 | |
33 | Ubiquitination | SQRYESLKGVDPKFL HHHHHHHCCCCHHHH | 67.19 | 21890473 | |
38 | Ubiquitination | SLKGVDPKFLRNMRF HHCCCCHHHHHHHHH | 53.20 | 23000965 | |
38 | Ubiquitination | SLKGVDPKFLRNMRF HHCCCCHHHHHHHHH | 53.20 | 21890473 | |
38 | Acetylation | SLKGVDPKFLRNMRF HHCCCCHHHHHHHHH | 53.20 | 25953088 | |
56 | Ubiquitination | HNKKGLKKMQANNAK HCHHHHHHHHHHHHH | 41.09 | 21906983 | |
63 | Ubiquitination | KMQANNAKAMSARAE HHHHHHHHHHHHHHH | 46.90 | 23000965 | |
63 | Acetylation | KMQANNAKAMSARAE HHHHHHHHHHHHHHH | 46.90 | 25953088 | |
66 | Phosphorylation | ANNAKAMSARAEAIK HHHHHHHHHHHHHHH | 21.33 | 22199227 | |
73 | Ubiquitination | SARAEAIKALVKPKE HHHHHHHHHHHCCHH | 42.59 | 21890473 | |
73 | Acetylation | SARAEAIKALVKPKE HHHHHHHHHHHCCHH | 42.59 | 25953088 | |
73 | Ubiquitination | SARAEAIKALVKPKE HHHHHHHHHHHCCHH | 42.59 | 23000965 | |
77 | Acetylation | EAIKALVKPKEVKPK HHHHHHHCCHHCCCC | 51.74 | 26051181 | |
77 | Ubiquitination | EAIKALVKPKEVKPK HHHHHHHCCHHCCCC | 51.74 | 23000965 | |
79 | Ubiquitination | IKALVKPKEVKPKIP HHHHHCCHHCCCCCC | 70.22 | 23000965 | |
82 | Ubiquitination | LVKPKEVKPKIPKGV HHCCHHCCCCCCCCH | 41.50 | 24816145 | |
82 | Acetylation | LVKPKEVKPKIPKGV HHCCHHCCCCCCCCH | 41.50 | 19608861 | |
84 | Ubiquitination | KPKEVKPKIPKGVSR CCHHCCCCCCCCHHH | 66.96 | - | |
90 | Phosphorylation | PKIPKGVSRKLDRLA CCCCCCHHHHHHHHH | 32.16 | 27282143 | |
95 | Methylation | GVSRKLDRLAYIAHP CHHHHHHHHHHHHCH | 31.49 | 115492009 | |
98 | Phosphorylation | RKLDRLAYIAHPKLG HHHHHHHHHHCHHCC | 11.84 | 22461510 | |
103 | Ubiquitination | LAYIAHPKLGKRARA HHHHHCHHCCHHHHH | 61.06 | 21890473 | |
103 | Acetylation | LAYIAHPKLGKRARA HHHHHCHHCCHHHHH | 61.06 | 23236377 | |
103 | Ubiquitination | LAYIAHPKLGKRARA HHHHHCHHCCHHHHH | 61.06 | 21906983 | |
106 | Ubiquitination | IAHPKLGKRARARIA HHCHHCCHHHHHHHH | 54.01 | - | |
114 | Ubiquitination | RARARIAKGLRLCRP HHHHHHHHHHHHHCH | 56.99 | 27667366 | |
114 | Methylation | RARARIAKGLRLCRP HHHHHHHHHHHHHCH | 56.99 | 72620571 | |
119 | S-palmitoylation | IAKGLRLCRPKAKAK HHHHHHHHCHHHHHH | 5.90 | 29575903 | |
122 | 2-Hydroxyisobutyrylation | GLRLCRPKAKAKAKA HHHHHCHHHHHHHHH | 43.07 | - | |
128 | Ubiquitination | PKAKAKAKAKDQTKA HHHHHHHHHHHHHHH | 56.09 | 23503661 | |
130 | Acetylation | AKAKAKAKDQTKAQA HHHHHHHHHHHHHHH | 50.06 | 26051181 | |
130 | Ubiquitination | AKAKAKAKDQTKAQA HHHHHHHHHHHHHHH | 50.06 | 22817900 | |
134 | Acetylation | AKAKDQTKAQAAAPA HHHHHHHHHHHHCCC | 32.63 | 23236377 | |
134 | Ubiquitination | AKAKDQTKAQAAAPA HHHHHHHHHHHHCCC | 32.63 | 21906983 | |
142 | O-linked_Glycosylation | AQAAAPASVPAQAPK HHHHCCCCCCCCCCC | 27.81 | 28510447 | |
142 | Phosphorylation | AQAAAPASVPAQAPK HHHHCCCCCCCCCCC | 27.81 | 30266825 | |
149 | Acetylation | SVPAQAPKRTQAPTK CCCCCCCCCCCCCCC | 71.71 | 26051181 | |
149 | 2-Hydroxyisobutyrylation | SVPAQAPKRTQAPTK CCCCCCCCCCCCCCC | 71.71 | - | |
149 | Ubiquitination | SVPAQAPKRTQAPTK CCCCCCCCCCCCCCC | 71.71 | 23000965 | |
149 | Methylation | SVPAQAPKRTQAPTK CCCCCCCCCCCCCCC | 71.71 | 24506953 | |
151 | O-linked_Glycosylation | PAQAPKRTQAPTKAS CCCCCCCCCCCCCCC | 34.90 | 28510447 | |
151 | Phosphorylation | PAQAPKRTQAPTKAS CCCCCCCCCCCCCCC | 34.90 | 24732914 | |
155 | Phosphorylation | PKRTQAPTKASE--- CCCCCCCCCCCC--- | 42.11 | 24732914 | |
156 | Ubiquitination | KRTQAPTKASE---- CCCCCCCCCCC---- | 49.18 | 33845483 | |
158 | Phosphorylation | TQAPTKASE------ CCCCCCCCC------ | 45.45 | 28355574 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RL29_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL29_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL29_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SYBU_HUMAN | SYBU | physical | 16169070 | |
CHD3_HUMAN | CHD3 | physical | 16169070 | |
RL6_HUMAN | RPL6 | physical | 22939629 | |
RL5_HUMAN | RPL5 | physical | 22939629 | |
RL8_HUMAN | RPL8 | physical | 22939629 | |
RL9_HUMAN | RPL9 | physical | 22939629 | |
RS15A_HUMAN | RPS15A | physical | 22939629 | |
RS23_HUMAN | RPS23 | physical | 22939629 | |
RS26_HUMAN | RPS26 | physical | 22939629 | |
RSSA_HUMAN | RPSA | physical | 22939629 | |
RS3_HUMAN | RPS3 | physical | 22939629 | |
RL4_HUMAN | RPL4 | physical | 22939629 | |
RS12_HUMAN | RPS12 | physical | 22939629 | |
RS6_HUMAN | RPS6 | physical | 22939629 | |
RS3A_HUMAN | RPS3A | physical | 22939629 | |
RS16_HUMAN | RPS16 | physical | 22939629 | |
RS20_HUMAN | RPS20 | physical | 22939629 | |
RS2_HUMAN | RPS2 | physical | 22939629 | |
RL7A_HUMAN | RPL7A | physical | 22939629 | |
RS24_HUMAN | RPS24 | physical | 22939629 | |
RL32_HUMAN | RPL32 | physical | 22939629 | |
RL38_HUMAN | RPL38 | physical | 22939629 | |
IL7RA_HUMAN | IL7R | physical | 23151878 | |
PRS8_HUMAN | PSMC5 | physical | 22863883 | |
RL9_HUMAN | RPL9 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-33 AND LYS-82, AND MASSSPECTROMETRY. | |
Methylation | |
Reference | PubMed |
"Characterization and analysis of posttranslational modifications ofthe human large cytoplasmic ribosomal subunit proteins by massspectrometry and Edman sequencing."; Odintsova T.I., Muller E.C., Ivanov A.V., Egorov T.A., Bienert R.,Vladimirov S.N., Kostka S., Otto A., Wittmann-Liebold B.,Karpova G.G.; J. Protein Chem. 22:249-258(2003). Cited for: PROTEIN SEQUENCE OF 2-15, MASS SPECTROMETRY, AND METHYLATION AT LYS-5. | |
Phosphorylation | |
Reference | PubMed |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY. | |
Ubiquitylation | |
Reference | PubMed |
"Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry."; Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.; Proteomics 7:868-874(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-56 AND LYS-73, AND MASSSPECTROMETRY. |